Southwest Autism Research and Resource Center | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients	Irritability Associated With Autism Spectrum Disorder	Recruiting	Phase 3	2026-09-25		NCT06690398
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder	Bipolar and Related Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, autism spectrum disorder, bipolar disorder, mood disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder, schizophrenia	Recruiting	Phase 3	2026-09-25		NCT06229210
ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)	autism, autism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder	Active, not recruiting	Phase 2	2026-07-20		NCT05889273
Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS	Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Sex Chromosome Disorders, X-linked disease, chromosomal disorder, fragile X syndrome, hereditary disease, inherited neurodegenerative disorder, intellectual disability, nervous system disorder	Active, not recruiting	Phase 2 / Phase 3	2026-05-27		NCT03802799
Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults	Chemically-Induced Disorders, anxiety, anxiety disorder, autism, autism spectrum disorder, cannabis dependence, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder, substance-related disorder	Recruiting	Phase 2	2026-03-30		NCT06526208